Arcadia Biosciences, Inc.

RKDA

Arcadia Biosciences, Inc.

RKDA

Insider Sentiment (TTM):

Last Purchase:2025-02-03Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:349,380Shares Outstanding:2,082,887Institutional Ownership Pct.:16.77%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	4	1	0	1	1	3	4	4	6	3	7	11
Short Term Investments	0	3	4	5	3	-	0	3	3	5	5	5
Accounts And Other Receivables Net Current	1	0	0	1	1	2	1	1	1	1	1	0
Inventory Net	1	1	1	1	1	1	1	1	1	2	1	3
Assets Held For Sale Not Part Of Disposal Group Cu…	-	-	-	-	-	-	0	0	0	0	0	0
Notes And Loans Receivable Net Current	-	-	0	0	0	2	2	2	2	-	0	-
Prepaid Expense And Other Assets Current	0	0	0	0	0	1	1	1	1	1	1	1
Assets Of Disposal Group Including Discontinued Op…	-	-	0	0	0	0	0	0	0	-	1	0
Assets Current	6	5	6	8	8	9	9	11	12	12	15	20
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	-	-	0	0	0	0	0	0	1	1	1	1
Intangible Assets Net Excluding Goodwill	0	0	0	0	0	0	0	0	0	0	0	0
Notes And Loans Receivable Net Noncurrent	-	-	0	0	0	4	4	4	4	-	0	-
Inventory Noncurrent	-	-	-	-	-	-	0	0	0	3	0	2
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	6	5	7	9	8	13	14	15	17	16	20	23
Liabilities And Stockhold…
Liabilities Current
Disposal Group Including Discontinued Operation As…	-	-	-	-	-	-	0	0	0	-	3	0
Accounts Payable And Accrued Liabilities Current	1	1	2	2	2	2	2	2	2	2	2	3
Operating Lease Liability Current	-	-	0	0	0	0	0	0	1	1	1	1
Liabilities Current	2	1	2	2	2	2	3	2	3	3	4	4
Other Liabilities Noncurrent	-	-	0	0	0	1	2	2	2	2	2	2
Liabilities	5	2	2	3	3	4	7	5	6	6	7	8
Liabilities Of Disposal Group Including Discontinu…	-	-	-	-	-	-	0	0	0	-	1	0
Operating Lease Liability Noncurrent	-	-	-	-	-	-	0	0	0	0	0	0
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	292	288	285	285	285	285	285	285	285	285	285	284
Retained Earnings Accumulated Deficit	-292	-286	-281	-280	-281	-276	-279	-275	-273	-274	-272	-269
Stockholders Equity	1	3	4	5	5	9	6	10	12	10	13	16
Liabilities And Stockholders Equity	6	5	7	9	8	13	14	15	17	16	20	23
Allowance For Doubtful Accounts Receivable Current	1	1	1	1	1	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Accumulated Other Comprehensive Income Loss Net Of…	-	-	-	-	-	-	0	0	0	0	0	0
Common Stock Shares Authorized	150	150	150	150	150	150	150	150	150	150	150	150
Common Stock Shares Issued	2	2	1	1	1	1	1	1	1	1	1	1
Shares Outstanding	2	2	1	1	1	1	1	1	1	1	1	1
Minority Interest	-	-	-	-	-	-	0	-0	-0	-0	-0	-0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	0.00%	-31.50%	-40.84%	-	-	-	-	-	-	-	-	-
2025	9.79%	-0.70%	-0.23%	-28.49%	-21.23%	-15.32%	-2.68%	-29.54%	-38.75%	-22.37%	-37.11%	-32.24%
2024	43.85%	48.06%	31.44%	-6.96%	-6.69%	28.33%	30.42%	50.00%	14.15%	-13.88%	18.08%	44.31%
2023	-	-	-	-	-	-	-11.35%	-3.69%	-21.85%	-6.79%	38.01%	43.35%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.49	3.79	3.09	3.67	4.12	3.99	3.61	4.60	4.61	4.05	4.17	5.15
Quick Ratio	2.88	3.04	2.42	2.94	3.10	3.08	2.89	4.02	4.05	3.22	3.71	4.18
Working Capital	4.09M	3.80M	4.30M	6.10M	5.74M	6.63M	6.68M	8.38M	9.74M	8.76M	11.38M	16.12M
Leverage & Debt
Debt to Equity	8.31	0.85	0.58	0.58	0.72	0.46	1.17	0.50	0.50	0.53	0.55	0.52
Interest Coverage TTM	-237.75	-165.61	-11.11	-5.90	-5.00	-1.62	-4.66	-1.29	-0.80	-7.05	-8.78	-11.85
Debt Ratio	0.89	0.46	0.37	0.37	0.42	0.31	0.54	0.33	0.33	0.35	0.36	0.34
Efficiency & Turnover
Asset Turnover TTM	0.69	0.52	0.48	0.43	0.43	0.36	0.30	0.23	0.19	0.18	0.18	0.09
Per Share Metrics
Diluted EPS TTM	-3.72	-4.48	-1.71	-3.69	-5.51	-1.48	-5.16	-4.27	-4.98	-5.16	-11.31	-11.38
Free Cash Flow Per Share TTM	-0.85	-2.04	-3.46	-4.45	-5.55	-5.86	-7.07	-8.49	-9.33	-11.06	-12.37	-9.96
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	34.60%	34.51%	36.23%	37.40%	37.38%	39.25%	40.88%	51.67%	54.01%	53.50%	51.19%	91.37%
Operating Profit Margin TTM	-80.15%	-80.05%	-51.46%	-66.22%	-74.64%	-29.28%	-72.79%	-16.87%	-9.22%	-90.83%	-137.00%	-320.68%
Net Profit Margin TTM	-234.53%	-195.94%	-48.15%	-98.60%	-140.21%	-38.58%	-140.42%	-130.74%	-160.79%	-166.90%	-314.01%	-595.73%
Growth Metrics
Net Revenue Growth (1Y)	-11.69%	-8.94%	-3.07%	15.30%	27.41%	24.14%	12.53%	71.62%	47.02%	-22.49%	-39.96%	-76.00%
Net Income Growth (1Y)	47.72%	362.45%	-66.77%	-13.04%	11.10%	-71.30%	-49.68%	-62.34%	-57.00%	-65.54%	-10.42%	-24.74%
EPS Growth (1Y)	-32.52%	203.30%	-66.88%	-13.26%	10.76%	-71.39%	-54.34%	-62.45%	-57.14%	-78.12%	-56.59%	-66.02%
Valuation Metrics
P/E TTM	-0.18	-0.31	-1.16	-0.94	-0.78	-2.01	-1.15	-0.64	-0.63	-0.43	-0.28	-0.29
P/B TTM	3.21	1.00	0.65	0.87	1.30	0.46	1.30	0.37	0.37	0.29	0.30	0.29
P/S TTM	0.43	0.60	0.56	0.92	1.10	0.78	1.61	0.84	1.02	0.71	0.87	1.75
Market Cap	2.03M	2.87M	2.71M	4.74M	5.89M	4.06M	8.07M	3.72M	4.29M	3.01M	3.87M	4.55M
Enterprise Value	-2.15M	1.92M	2.45M	3.62M	4.51M	898.20K	3.83M	-212.95K	-1.21M	-307.74K	-2.65M	-6.06M
Calculated Values
Free Cash Flow TTM	-2.54M	-4.25M	-4.74M	-6.09M	-7.58M	-8.01M	-9.64M	-11.58M	-12.71M	-15.06M	-15.30M	-13.54M
Net Debt	-4.18M	-954.00K	-259.00K	-1.12M	-1.38M	-3.16M	-4.24M	-3.94M	-5.50M	-3.32M	-6.52M	-10.61M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-02-03Purchase

Owner: Schaefer, Thomas J.

Title: Chief Executive Officer

Shares: 700

Price/Share: $2.49

Value: $1,743.00

Shares Owned: 2,819

Relationship: Officer

Ownership: Direct

2025-02-03Purchase

Owner: Kawakami, Mark

Title: Chief Financial Officer

Shares: 700

Price/Share: $2.49

Value: $1,743.00

Shares Owned: 2,681

Relationship: Officer

Ownership: Direct

2024-08-01Purchase

Owner: Kawakami, Mark

Title: Chief Financial Officer

Shares: 700

Price/Share: $2.06

Value: $1,442.00

Shares Owned: 1,981

Relationship: Officer

Ownership: Direct

2024-08-01Purchase

Owner: Schaefer, Thomas J.

Title: Chief Executive Officer

Shares: 700

Price/Share: $2.06

Value: $1,442.00

Shares Owned: 2,119

Relationship: Officer

Ownership: Direct

2024-02-01Purchase

Owner: Schaefer, Thomas J.

Title: Chief Financial Officer

Shares: 700

Price/Share: $2.06

Value: $1,442.00

Shares Owned: 1,419

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-02-03	Schaefer, Thomas J.	Officer	Chief Executive Officer	Direct	Purchase	700	2.49	$1,743.00	2,819	4
2025-02-03	Kawakami, Mark	Officer	Chief Financial Officer	Direct	Purchase	700	2.49	$1,743.00	2,681	4
2024-08-01	Kawakami, Mark	Officer	Chief Financial Officer	Direct	Purchase	700	2.06	$1,442.00	1,981	4
2024-08-01	Schaefer, Thomas J.	Officer	Chief Executive Officer	Direct	Purchase	700	2.06	$1,442.00	2,119	4
2024-02-01	Schaefer, Thomas J.	Officer	Chief Financial Officer	Direct	Purchase	700	2.06	$1,442.00	1,419	4
2023-08-04	Schaefer, Thomas J.	Officer	Chief Financial Officer	Direct	Purchase	649	3.67	$2,381.83	719	4
2023-05-30	Jacot, Stanley Jr	Officer	Chief Executive Officer	Direct	Purchase	5,000	4.31	$21,550.00	5,000	4
2023-02-01	Schaefer, Thomas J.	Officer	Chief Financial Officer	Direct	Purchase	700	0.23	$161.00	2,800	4
2022-08-01	Haley, Pamela	Officer	Chief Financial Officer	Direct	Purchase	700	0.70	$490.00	5,088	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

16.77%

Inst. Shares: 349,380

Shares Outstanding: 2,082,887

2025-12-31

2.86%

Inst. Shares: 39,114

Shares Outstanding: 1,368,057

2025-09-30

4.79%

Inst. Shares: 65,469

Shares Outstanding: 1,367,192

2025-06-30

4.33%

Inst. Shares: 59,154

Shares Outstanding: 1,367,040

2025-03-31

5.60%

Inst. Shares: 76,493

Shares Outstanding: 1,366,060

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	349,380	2,082,887	16.77%
2025-12-31	39,114	1,368,057	2.86%
2025-09-30	65,469	1,367,192	4.79%
2025-06-30	59,154	1,367,040	4.33%
2025-03-31	76,493	1,366,060	5.60%
2024-12-31	78,535	1,363,303	5.76%
2024-09-30	53,913	1,363,753	3.95%
2024-06-30	28,701	1,362,840	2.11%
2024-03-31	70,513	1,361,657	5.18%
2023-12-31	127,170	1,236,934	10.28%
2023-09-30	47,444	1,359,511	3.49%
2023-06-30	138,672	1,358,395	10.21%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Arcadia Biosciences, Inc. (RKDA) — SEC Financial Statements & Analysis

Arcadia Biosciences, Inc. (RKDA) is a crude petroleum & natural gas company, incorporated in DE. Arcadia Biosciences, Inc. trades on Nasdaq as: RKDA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Arcadia Biosciences, Inc. reported a -11.69% year-over-year revenue growth, a Gross Profit Margin of 34.60% (TTM), a Debt-to-Equity ratio of 8.31x, a Price-to-Sales (P/S) ratio of 0.43x (TTM), a Price-to-Book (P/B) ratio of 3.21x (TTM), at a market cap of $2.03M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -11.69%
Gross Profit Margin TTM: 34.60%
Debt To Equity: 8.31x
P/S TTM: 0.43x
P/B TTM: 3.21x
Market Cap: $2.03M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Arcadia Biosciences, Inc. in?

Arcadia Biosciences, Inc. (RKDA) operates in the Crude Petroleum & Natural Gas industry.

What is RKDA's market cap?

Arcadia Biosciences, Inc. (RKDA) has a market capitalization of $2.03M as of 2026-06-30.

What exchange does RKDA trade on?

Arcadia Biosciences, Inc. (RKDA) trades on the Nasdaq.

Where is Arcadia Biosciences, Inc. incorporated?

Arcadia Biosciences, Inc. is incorporated in DE.